Beschreibung
Written specifically for cancer patients and non-oncologist care providers to serve as a resource when seeking immunotherapy as a treatment option Detailed focus on various cancers provides disease-specific insights in applying immunotherapy to each disease Provides direct evidence based on clinical studies and observations to address the risks and benefits of cancer immunotherapy Comprehensively updated and expanded to include coverage of cutting-edge therapies and additional disease-specific scenarios
Autorenporträt
Haidong Dong is a tumour immunologist who co-discovered B7-H1 (PD-L1) in 1998 at the Mayo Clinic, USA. His research is on mechanisms of cancer immunity and developments of cancer immunotherapy. Svetomir Markovic is a medical oncologist and physician scientist at the Mayo Clinic who specializes in the care of patients with metastatic melanoma. His research is focused on melanoma immune biology and immunotherapy.
Herstellerkennzeichnung:
Springer Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE
E-Mail: juergen.hartmann@springer.com
